Dr. A.S. (Ajay) Bhaskarabhatla

Bhaskarabhatla, A., Deng, Y., & Liu, Y. (2024). Open disclosure using invention pledges: a case study of IBM. Journal of Technology Transfer, 49(4), 1532-1566. https://doi.org/10.1007/s10961-023-10050-w

Benischke, M., Bhaskarabhatla, A., & Singh, R. (2024). The Effect of Incoming Board Interlocks With Public Firms on Private Firms’ Survival: Large-Scale Evidence From India. Journal of Management, 50(5), 1939-1971. https://doi.org/10.1177/01492063231164971

Benischke, M., & Bhaskarabhatla, A. (2024). Negative Incentives and Regulatory Capture: Noncompliance with Price Ceilings on Essential Medicines in India. Journal of Management Studies, 61(2), 336-374. https://doi.org/10.1111/joms.12885

Antonecchia, G., & Bhaskarabhatla, A. (2023). How firms compete when they set identical prices: Nonprice strategies in the Indian biscuit industry. Journal of Economics and Management Strategy, 32(4), 733-756. https://doi.org/10.1111/jems.12518

Bhaskarabhatla, A., Anurag, P., Chatterjee, C., & Pennings, E. (2021). How does regulation impact strategic repositioning by firms across submarkets? Evidence from the Indian pharmaceutical industry. Strategy Science, 6(3), 209-227. https://doi.org/10.1287/stsc.2020.0121

Bhaskarabhatla, A., Cabral, L., Hegde, D., & Peeters, T. (2021). Are inventors or firms the engines of innovation? Management Science, 67(6), 3899-3920. https://doi.org/10.1287/mnsc.2020.3646

Bhaskarabhatla, A. (2020). Maximum Resale Price Maintenance and Retailer Cartel Profits: Evidence from the Indian Pharmaceutical Industry. Antitrust Law Journal, 83(1), 41-73.

Adbi, A., Bhaskarabhatla, A., & Chatterjee, C. (2018). Stakeholder Orientation and Market Impact: Evidence from India. Journal of Business Ethics, 161, 479-496. https://doi.org/10.1007/s10551-018-3919-x

Bhaskarabhatla, A., & Chatterjee, C. (2017). Whither competition law in Indian pharmaceutical markets? Evidence from arbitration data of CCI and COMPAT. Journal of Antitrust Enforcement, 5(2), 291-298. https://doi.org/10.1093/jaenfo/jnx007

Bhaskarabhatla, A., Anurag, P., Chatterjee, C., & Pennings, E. (2017). Mitigating Regulatory Impact: The Case of Partial Price Controls on Metformin in India. Health Policy and Planning, 32(2), 194-204. https://doi.org/10.1093/heapol/czw109

Bhaskarabhatla, A., & Chirantan, C. (2017). The Role of Physicians in Prescribing Irrational Fixed-Dose Combination Medicines in India. Social Science & Medicine, 174(February), 179-187. https://doi.org/10.1016/j.socscimed.2016.12.022

Bhaskarabhatla, A. (2016). The Moderating Role of Submarket Dynamics on the Product Customization–Firm Survival Relationship. Organization Science, 27(4), 1049-1064. https://doi.org/10.1287/orsc.2016.1074

Bhaskarabhatla, A., Chatterjee, C., & Karreman, B. (2016). Hit where it hurts: Cartel policing using targeted sales and supply embargoes. The Journal of Law and Economics, 59(4), 805-846. https://doi.org/10.1086/691093

Bhaskarabhatla, A., & Klepper, S. (2014). Latent Submarket Dynamics and Industry Evolution: Lessons from the U.S. Laser Industry. Industrial and Corporate Change (online version), 23(6), 1381-1415. https://doi.org/10.1093/icc/dtt060

Bhaskarabhatla, A., & Hegde, D. (2014). An Organizational Perspective on Patenting and Open Innovation. Organization Science, 25(6), 1744-1763. https://doi.org/10.1287/orsc.2014.0911

Bhaskarabhatla, A., & Pennings, E. (2014). Defensive Disclosure of Patentable Inventions under Antitrust Enforcement. Industry and Innovation, 21(7), 533-552. https://doi.org/10.1080/13662716.2014.987452